High levels of ACLY in CRC cells were shown to promote metastasis and resistance to chemotherapy, among others through interaction with β-catenin 1 [64], acetylation and AKT phosphorylation events, thus posing as one key player in lipid-associated rewiring [65,66]. The gene discussed is AKT1; the disease is colorectal carcinoma.